Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia
Clinical trial NCT00895297 · TERMINATED
Trial details
- NCT number
- NCT00895297
- Sponsor
- European Society for Blood and Marrow Transplantation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.